Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin and endothelial function in stable coronary artery disease
2005-006113-40Phase 3Active
- Sponsor
- University Heart Center Hamburg
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of enoxaparin in coronary arteriosclerosis, sponsored by University Heart Center Hamburg. Primary endpoint: Change in endothelial function. Started Oct 2006; status: active.
02
Drugs
enoxaparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-006113-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006113-40.